MENLO PARK, Calif.--(BUSINESS WIRE)--Intersect ENT, Inc. (NASDAQ:XENT), a company dedicated to improving the quality of life for patients with ear, nose and throat conditions, today reported financial results for the second quarter ended June 30, 2015. Recent Highlights
•Achieved revenue of $15.2 million, an increase of 77% over Q2 2014.
Help employers find you! Check out all the jobs and post your resume.
